News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
477
Sources here
22
Companies here
9
Search results Stored financial headlines

Active search

477 matching headlines

Ticker or company: LEDMain company stories
Clear

Eledon Pharmaceuticals (NASDAQ:ELDN) Upgraded at Wall Street Zen

Wall Street Zen upgraded Eledon Pharmaceuticals (NASDAQ:ELDN) from "strong sell" to "sell," though the broader analyst consensus remains "Hold" with a $9.67 target price. The company reported a quarterly loss of $0.27 per share, missing estimates, and its shares opened at $3.54. Institutional investors …

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (TDY) is acquiring Varex Imaging (VREX) for $18.90 per share, a 52% premium, valuing the transaction at $1.1 billion. The acquisition aims to fill gaps in Teledyne's imaging portfolio, particularly in specialized X-ray technologies and high-radiation applications, strengthening its Digital Imaging segment. …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inside Teledyne’s Bold Bet on the Future of Medical Imaging

Teledyne Technologies announced the acquisition of Varex Imaging Corporation for $1.1 billion, an all-cash deal at $18.90 per share. This strategic move allows Teledyne to expand its presence in high-margin healthcare diagnostics and industrial non-destructive inspection by integrating Varex’s specialized X-ray tube and detector …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

T. Rowe Price Associates (IBP) discloses 4.3% holding in Installed Building Products

T. Rowe Price Associates, Inc. has filed a Schedule 13G/A report disclosing a 4.3% beneficial ownership stake in Installed Building Products (IBP), totaling 1,161,708 shares. The firm has sole voting power over 1,159,558 shares and sole dispositive power over all 1,161,708 shares, while explicitly …

IBP main company
Sharemaestro market context Price below Trend Line 52 weeks -10.9% IBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eledon Pharmaceuticals (NASDAQ:ELDN) Posts Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Eledon Pharmaceuticals (NASDAQ:ELDN) reported a quarterly loss of $0.27 per share, missing the consensus estimate by $0.11. The stock subsequently fell 1.9% to $3.70, with a consensus "Hold" rating and an average price target of $9.67 from analysts. Institutional investors hold a significant portion …

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

METTLER TOLEDO Introduces LightningBuild Program For Four-Week Delivery

METTLER TOLEDO Product Inspection Group has launched its new LightningBuild program, offering a four-week delivery time for select product inspection systems. The program currently includes the X12 LightningBuild x-ray inspection system and the C31 LightningBuild checkweigher, designed to help food and pharmaceutical manufacturers quickly …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eledon Pharmaceuticals Reports Q2 2026 Form 10-Q Highlighting Going Concern and Funding Challenges

Eledon Pharmaceuticals' Q2 2026 Form 10-Q filing reveals significant concerns about its ability to continue as a going concern due to ongoing operating losses and the critical need for additional financing. The company anticipates continued losses and warns that failure to secure more capital …

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K Eledon Pharmaceuticals Inc For: 13 August By Investing.com

This article reports on the filing of Form 8K by Eledon Pharmaceuticals Inc. for August 13. It includes a brief mention of the company's stock symbol (ELDN) and its current performance (-4.62%), alongside general market data and other news headlines.

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne Technologies (TDY) Director VON SCHACK WESLEY W Sells 468 Shares

Teledyne Technologies (TDY) Director VON SCHACK WESLEY W sold 468 shares for approximately $321,342.84, with the company's stock currently appearing Modestly Overvalued according to GuruFocus's GF Value. The insider selling trend, combined with the stock trading at a premium to its historical and industry …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eledon Pharmaceuticals (ELDN) widens Q2 loss while advancing tegoprubart to Phase 3

Eledon Pharmaceuticals reported a wider Q2 2026 net loss of $31.6 million, compared to $11.2 million a year prior, primarily due to a non-cash loss from warrant liability remeasurement. Despite this, the company is advancing its lead drug, tegoprubart, to a global Phase 3 …

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eledon Islet Study: All 12 Patients Reached Insulin Independence

Eledon Pharmaceuticals reported positive second-quarter 2026 financial results and significant clinical progress for its lead anti-CD40L antibody, tegoprubart. A successful End-of-Phase 2 FDA meeting supports a global Phase 3 kidney transplantation trial set to enroll approximately 600 patients in late 2026. Notably, an islet …

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne technologies director sells $321,342 in shares

A director at Teledyne Technologies Inc. (NYSE:TDY), Wesley W. von Schack, sold 468 shares of company stock for a total of $321,342 on August 12, 2026. This transaction occurred near the stock's 52-week high, with the company also recently reporting strong second-quarter results, exceeding …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne Technologies Insider Sold Shares Worth $321,343, According to a Recent SEC Filing

An insider at Teledyne Technologies recently sold shares valued at $321,343, as detailed in a recent SEC filing. This transaction follows other recent news for the company, including analyst target price adjustments and an announcement to acquire Varex Imaging Corporation for $1.1 billion. Teledyne …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fitch upgrades Teledyne Technologies rating on strong cash flow

Fitch Ratings has upgraded Teledyne Technologies Inc.'s Long-Term Issuer Default Rating to 'BBB+' from 'BBB', reflecting the company's strong financial profile, robust free cash flow generation, and disciplined capital allocation. The upgrade also considers Teledyne's advanced technology, diversified market exposure, and solid market positions, …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Eledon Pharmaceuticals announced its second quarter 2026 financial results and key business highlights, including successful progress in its tegoprubart program. The company is on track to initiate a global Phase 3 kidney transplantation trial in late 2026, supported by positive long-term Phase 2 BESTOW …

ELDN main company
Sharemaestro market context Trend signal active 52 weeks +36.2% ELDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mettler Toledo Introduces Rapid Inspection Systems Delivery System

Mettler Toledo Product Inspection Group has launched LightningBuild, a program offering select product inspection systems with a four-week delivery time. This initiative includes the X12 LightningBuild X-ray inspection system and the C31 LightningBuild checkweigher, aiming to help food and pharmaceutical manufacturers quickly adapt to …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne Marine Deploys Gavia UUV In AUKUS Exercise Lanternfish 2026

Teledyne Marine participated in Exercise Lanternfish 2026, an AUKUS Pillar 2 exercise, deploying its Gavia unmanned undersea vehicle (UUV) to advance seabed warfare capabilities and protect critical undersea infrastructure. Working with the UK Royal Navy and Royal Australian Navy, Teledyne Marine provided technical expertise …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IBP (IBP) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 10 a.m. ET CALL PARTICIPANTS Managing Director, Investor Relations - Ryan Ricketts Chairman and Chief Executive Officer - Jeffrey Edwards Executive Vice President and Chief Financial Officer - Michael Miller Chief Administrative and …

IBP main company
Sharemaestro market context Price below Trend Line 52 weeks -10.9% IBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street Analysts Think DoubleDown Interactive (DDI) Could Surge 45.96%: Read This Before Placing a Bet

DoubleDown Interactive (DDI) recently closed at $12.25, and Wall Street analysts project a 46% upside potential with a mean price target of $17.88. While analyst price targets should be treated with skepticism due to potential biases, a strong agreement among analysts and positive earnings …

DDI main company
Sharemaestro market context Trend signal active 52 weeks +40.9% DDI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne Marine Advances Allied Undersea Capabilities During AUKUS Exercise Lanternfish

Teledyne Marine participated in Exercise Lanternfish 2026, an AUKUS Pillar 2 exercise aimed at enhancing seabed warfare capabilities and protecting critical undersea infrastructure. The company supported the U.K. Royal Navy and Royal Australian Navy, deploying its Gavia unmanned undersea vehicle (UUV) with specialized modules, …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Morgan Stanley Adjusts PT on Teledyne Technologies to $715 From $680, Maintains Equalweight Rating

Morgan Stanley has increased its price target for Teledyne Technologies (TDY) to $715 from $680, while maintaining an Equalweight rating on the stock. This adjustment reflects a revised outlook from the firm on the company's valuation. Teledyne Technologies specializes in electronic and technical subsystems, …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mettler-Toledo International, Inc. (NYSE:MTD) Given Consensus Rating of "Hold" by Analysts

Mettler-Toledo International, Inc. (NYSE:MTD) has received a "Hold" consensus rating from analysts, with seven out of thirteen recommending holding the stock and six suggesting a buy. The average 12-month price target is set at approximately $1,461. The company recently surpassed quarterly earnings expectations, reporting …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Could Teledyne Technologies (TDY) Defense Showcase Mean For Its Growth Case?

Teledyne Technologies showcased its defense, space, and missile defense solutions at a recent symposium, emphasizing its role in U.S. national security programs. This showcase reinforces the company's focus on defense and space exposure as a key driver for earnings visibility. Investors should monitor upcoming …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DoubleDown Interactive (DDI) Stock Draws Focus To Cash Rich Margins

DoubleDown Interactive (DDI) stock, despite a slight dip, is drawing attention for its strong financial health, including a 42% adjusted EBITDA margin and US$553.8m in cash and short-term investments. The company's Q2 2026 earnings showed increased revenue and net income, with a growing direct-to-consumer …

DDI main company
Sharemaestro market context Trend signal active 52 weeks +40.9% DDI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne Technologies Director Sold Shares Worth Over $4.3M

Lorne Simon M, a Director at Teledyne Technologies, reported selling shares of the company's common stock on August 12, 2026. The transactions were executed in multiple trades at various weighted average prices, totaling $4,387,532. After these sales, Lorne Simon M directly owns 55,783 shares, …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne director Simon Lorne sells $4.39m in company stock

Teledyne director Simon Lorne sold 6,449 shares of company stock for approximately $4.39 million, holding 55,783 shares directly afterward. This sale occurred as Teledyne's stock is near its 52-week high and follows a strong Q2 2026 earnings report that surpassed analyst expectations, leading to …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teledyne Technologies (TDY) lists option-based common stock for potential sale

Teledyne Technologies Inc. has filed a Form 144 notice regarding the potential sale of common stock acquired through prior option exercises. The filing identifies multiple blocks of shares stemming from option grants in 2011 and 2013, with cash exercises occurring in 2021, 2022, and …

TDY main company
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup positive 56.8% TDY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context